Antibodies

Antibodies is an international, peer-reviewed, open access journal on immunoglobulins, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
  • Journal Rank: CiteScore - Q1 (Drug Discovery)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 21.7 days after submission; acceptance to publication is undertaken in 5.6 days (median values for papers published in this journal in the first half of 2023).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor: 4.7 (2022); 5-Year Impact Factor: 4.9 (2022)
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in Antibodies
Autoimmune and Inflammatory Rheumatic Diseases: Potential Biomarkers, Antibodies Response and New Therapies Guest Editor: Marino Paroli
Deadline: 20 September 2023
Special Issue in Antibodies
Application of Phage Display Technology in the Development of Antibodies Guest Editor: Theam Soon Lim
Deadline: 30 November 2023
Special Issue in Antibodies
Applications of Machine Learning and Bioinformatics to Antibody Discovery Guest Editor: Kannan Tharakaraman
Deadline: 20 December 2023
Special Issue in Antibodies
Antiphospholipid Antibodies Guest Editors: Md Asiful Islam, Przemysław Kotyla
Deadline: 31 December 2023
Topical Collection in Antibodies
Computational Antibody and Antigen Design Collection Editor: Buyong Ma
Back to TopTop